Okayama, Japan

Hiroshi Inooka

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Kumamoto University, Yamada Bee Company, Inc.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Inooka. Retrieved from https://idiyas.com/inventor/hiroshi-inooka-x1dvtik1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Inooka: Innovator in Mucosal Immunomodulation

Introduction

Hiroshi Inooka is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of immunology, particularly through his innovative work on mucosal immunomodulators. His research has the potential to impact various therapeutic applications.

Latest Patents

Hiroshi Inooka holds a patent for a mucosal immunomodulator. The invention provides a formulation comprising, as an active ingredient, at least one compound selected from a specific group of compounds represented by designated formulas, along with their salts. This patent highlights his commitment to advancing medical science.

Career Highlights

Throughout his career, Hiroshi Inooka has worked with reputable organizations, including Yamada Bee Company, Inc. and Kumamoto University. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research endeavors.

Collaborations

Hiroshi has collaborated with notable colleagues such as Shogo Misumi and Tomoki Ikuta. These partnerships have contributed to the development of his innovative ideas and research projects.

Conclusion

Hiroshi Inooka's work in mucosal immunomodulation exemplifies the impact of innovative research in the medical field. His contributions continue to pave the way for advancements in immunology and therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…